Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chronic Pain × Tapentadol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 4 Neoplasms 3 Chronic Pain 1 Cancer Pain 1 Agnosia 1

Interventions

Sodium Chloride 2 Tapentadol 1 Ropivacaine 1 Pregabalin 1 Meloxicam 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1 Ketamine 1 Fentanyl 1 Educational Status 1 Anti-Inflammatory Agents, Non-Steroidal 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated

31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡